EuroPCR 2018: SPYRAL HTN-ON MED - Justin Davies, David Kandzari

EuroPCR 2018: SPYRAL HTN-ON MED - Justin Davies, David Kandzari

Hypertension management in 2022: Latest data on renal denervation from #EuroPCR 2022Подробнее

Hypertension management in 2022: Latest data on renal denervation from #EuroPCR 2022

EuroPCR 2018 Highlights - Interventions for HypertensionПодробнее

EuroPCR 2018 Highlights - Interventions for Hypertension

Renal denervation based therapies for hypertension - EuroPCR 2018Подробнее

Renal denervation based therapies for hypertension - EuroPCR 2018

AHA 22: SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension | Dr David KandzariПодробнее

AHA 22: SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension | Dr David Kandzari

SPYRAL HTN-ON MED ResultsПодробнее

SPYRAL HTN-ON MED Results

Renal Denervation is Still AliveПодробнее

Renal Denervation is Still Alive

Dr. David KandzariПодробнее

Dr. David Kandzari

ACC 22: 3-year Efficacy Outcomes from the SPYRAL HTN-ON MED Med Pilot Study | Prof Felix MahfoudПодробнее

ACC 22: 3-year Efficacy Outcomes from the SPYRAL HTN-ON MED Med Pilot Study | Prof Felix Mahfoud

Renal denervation writes the next chapter in hypertension managementПодробнее

Renal denervation writes the next chapter in hypertension management

EuroPCR 2018 Day 2: renal denervation, drugs & devices and moreПодробнее

EuroPCR 2018 Day 2: renal denervation, drugs & devices and more